Back to mobile site

Leerink Partners Reiterates Outperform Rating on DENTSPLY SIRONA (XRAY)

October 25, 2024 5:40 AM EDT Send to a Friend
Leerink Partners analyst Michael Cherny reiterated an Outperform rating and $32.00 price target on DENTSPLY SIRONA (NASDAQ: XRAY).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login